Facility Management for Malaria Vaccine Testing

The Master IDIQ for Facility Management of Malaria Vaccine Testing is a specialized contract vehicle focused on operating research facilities for conducting human subject trials of malaria vaccines. Awarded by the National Institutes of Health (NIH), this contract enables systematic testing of potential malaria vaccine candidates through controlled clinical research environments. The primary objective is to support advanced medical research by providing infrastructure and operational capabilities for adult human subject vaccine testing.

The available task orders demonstrate a consistent scope of facility management for malaria vaccine research, with each delivery order valuing between $14,000 and $19,500 and sharing an identical ultimate completion date of November 1, 2020. All task orders were awarded on September 15, 2016, with firm fixed price pricing and no specific small business set-aside designations. The contract vehicle's total shared ceiling is $24,426,295, suggesting substantial potential for additional research-oriented task orders. While specific prime contractors are not identified in the provided documentation, the contract appears to be a targeted, specialized research support mechanism within the NIH's medical research infrastructure, likely involving facilities with specialized capabilities for conducting controlled vaccine testing protocols.